Shots: Thermo Fischer acquires Brammer Bio, in all stock transaction for $1.7B in cash with its viral vector manufacturing techniques in gene and cell therapies. The transaction is expected to […]readmore
Tags : Acquire
Shots: Alcon acquires PowerVision, in all stock transaction paying $285M to PowerVision with additional payment based on regulatory & commercial milestones expected to initiate in 2023 The focus of the […]readmore
Shots: Smith & Nephew acquires Osiris Therapeutics, in all stock transaction for $19/share at a premium of 37% making the total deal value $660M. The transaction is expected to close […]readmore
Shots: Exactech acquires XpandOrtho, in all-stock transaction to improve Exatech’s surgery experience and to improves patients’ outcome experiencing knee surgery The focus of the acquisition is to enhance Exatech’s GPS […]readmore
Shots: Fujifilm acquires Biogen’s subsidiary having the production capacity of 90,000L biologics, in all-stock transaction for $890M. The acquisition is expected to be complete in H2’19 The focus of an […]readmore
Shots: Pacira acquires MyoScience, in all stock transaction for $220M. MyoScience to receive $120M upfront and $100M as regulatory and commercial milestones. The transaction is expected to close in Apr’2019 […]readmore
Shots: Biogen acquires Nightstar Therapeutics, in all stock transaction with its lead candidates NSR-REP1 & NSR-RPGR. Nightstar Therapeutics to receive $25.50 /share in cash for one day premium of 68% […]readmore
Shots: Ipsen to acquire Clementia Pharmaceuticals in all stock transaction, with its lead candidate palovarotene, for $25/share making the total deal value of $1.04B In H2’19, Ipsen plans to file […]readmore
Shots: Danaher to acquire biopharma unit of GE Life Sciences (GE Biopharma), in all stock transaction making total deal value of $21.4 B. GE Biopharma to receive $21.4B, including $18B […]readmore
Shots: Roche acquires Spark Therapeutics, in all stock transaction for $114.50 /share in cash, making the total deal value $4.3B. Spark to receive premium of 122% based on its last […]readmore